Mid-term outcomes after staged transcatheter management of severe native aortic regurgitation and cardiac resynchronisation therapy in a high-risk patient

30 August 2026 (17:12 - 17:24)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Doctor Tanya Camuz

Istanbul University-Cerrahpasa Institute of Cardiology, Istanbul (Turkiye)

4 More presentations in this session

Presentation thumbnail

Transcatheter aortic valve implantation under extracorporeal membrane oxygenation in a patient with cardiogenic shock due to a degenerated bioprosthesis

Doctor M. Rodrigues (Rio de Janeiro, BR)

Presentation thumbnail

Navigating the perfect storm: Cardiac Arrest, AMA, and redo TAVI.

Doctor R. Alotaibi (Riyadh, SA)

Presentation thumbnail

Sequential mavacamten therapy and TAVRtavr in an elderly patient with concomitant severe aortic stenosis and obstructive hypertrophic cardiomyopathy

Doctor Y. Wu (Beijing, CN)

Presentation thumbnail

Between a rock and a hard place

Doctor R. Murray (Kuala Lumpur, MY)

Access the full session

Session thumbnail

Transcatheter aortic valve implantation in challenging clinical scenarios

The Event

Event poster

ESC Congress 2026

30 August 2026 17:12 CET

You may be interested in

Congress Session

Navigating through heart failure device therapies

18 May 2025

Congress Presentation

Transcatheter treatment of severe mitral regurgitation in high surgical risk patients: analysis of clinical and echocardiographic data from a referral center

13 December 2024

Congress Presentation

Prognostic predictors after TAVI in patients with severe aortic stenosis and concomitant aortic regurgitation

29 August 2025

Congress Session

Failing valves and beyond

19 May 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources